Analysis of the CTS-6 Questionnaire and Development of a Carpal Tunnel Syndrome Decision Tree

CTS-6问卷分析及腕管综合征决策树的构建

阅读:1

Abstract

PURPOSE: Carpal tunnel syndrome (CTS) is a common compressive neuropathy with no gold standard for diagnosis. The CTS-6 questionnaire is a previously validated tool used to determine the likelihood that a patient has CTS; however, numbness and tingling in the median nerve distribution is not a required symptom for a positive test result. The purpose of this study was to re-evaluate the components of the CTS-6 questionnaire to determine if a more succinct carpal tunnel screening tool could be developed. METHODS: A database of 295 upper extremities who had previously undergone CTS-6 testing were analyzed. All charts were reviewed to determine which patients were offered carpal tunnel release, used as the reference standard for a true positive diagnosis. We split the data into training (80%) and test (20%) sets that were used to develop and validate a decision tree for CTS, respectively. The performance metrics for this decision tree, the CTS-6 questionnaire, and variations of the questionnaire were calculated. RESULTS: The CTS-6 had a sensitivity of 76%, specificity of 60%, and overall accuracy of 71%. Variations of the CTS-6 had sensitivity of 72% to 93% and specificity of 37% to 65%, where a higher sensitivity came at the cost of lower specificity. The CTS decision tree had the best performance metrics, with 100% sensitivity, 65% specificity, and 88% overall accuracy. CONCLUSIONS: A simple CTS decision tree has the potential to be an efficient screening tool to assist in determining which patients may be a good candidate for carpal tunnel release. Further investigation into this screening tool in a larger patient population should be performed to determine its usefulness in a clinical setting. TYPE OF STUDY/LEVEL OF EVIDENCE: Diagnostic IV.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。